Categories
Brands
Active Ingredient
Warehouses
Liraglutide Information
Click here to view all Liraglutide productsThe information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.
Liraglutide is a medication that is used to treat type 2 diabetes and obesity. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists.
Liraglutide works by mimicking the effects of a hormone called GLP-1, which is naturally produced in the body. GLP-1 helps regulate blood sugar levels by stimulating the release of insulin from the pancreas and reducing the production of glucose in the liver. It also slows down the emptying of the stomach, which helps to reduce appetite and promote a feeling of fullness.
By activating the GLP-1 receptors, liraglutide helps to lower blood sugar levels, improve insulin sensitivity, and promote weight loss. It is typically administered as a once-daily injection and is often used in combination with diet and exercise to manage diabetes or as part of a comprehensive weight loss program.
Synonyms of Liraglutide
- Liraglutide
- victoza
- Liraglutida
- Liraglutidum
- NN2211
- 204656-20-2
- Saxenda
- NN-2211
- NN 2211
- Liraglutidum [INN-Latin]
- Liraglutida [INN-Spanish]
- UNII-839I73S42A
- Liraglutide recombinant
- HSDB 8205
- Liraglutide [USAN:INN]
- Liraglutide (rDNA origin)
- NNC 90-1170
- CHEMBL4084119
- CHEBI:71193
- DTXSID60174433
- Liraglutide [USAN:INN:BAN:JAN]
- 839I73S42A
- NN-9924
- NNC-90-1170
- liraglutide rDNA origin
- N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide
- liraglutide [rDNA origin]
- N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
- liraglutide [rNDA origin] injection
- Arg34Lys26-(N-epsilon-(gamma-Glu(N-alpha-hexadecanoyl)))-GLP-1(7-37)
- N(sup 26)-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide
- C172H265N43O51
- Victoza (TN)
- C172-H265-N43-O51
- Liraglutidum (Latin)
- D03GOI
- LIRAGLUTIDE (MART.)
- GTPL1133
- DTXCID6096924
- N26-(Hexadecanoyl-gamma-glutamyl)-(34-arginine)GLP-1-(7-37)-peptide
- A10BJ02
- EX-A2418
- BDBM50240819
- NN9924
- AKOS037435224
- AS-56276
- A16115
- XULTOPHY 100/3.6 COMPONENT LIRAGLUTIDE
- LIRAGLUTIDE COMPONENT OF XULTOPHY 100/3.6
- ARG(SUP 34)LYS(SUP 26)-(N-epsilon-(gamma-GLU(N-alpha-HEXADECANOYL)))-GLP-1(7-37)
- N(SUP epsilon26)-(N-HEXADECANOYL-L-gamma-GLUTAMYL)-(34-L-ARGININE)GLUCAGON-LIKE PEPTIDE 1-(7-37)-PEPTIDE
- N26-(N-Hexadecanoyl-L-gamma-glutamyl)-(34-L-arginine)glucagon-like peptide 1-(7-37)-peptide